Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
|
|
Reuters NewMedia - Tuesday December 12, 2000
"My feeling and fond hope is that I, or my successor, will some day be in front of you, telling you the efficacy of this HIV program," Dr. Edward Scolnick, head of Merck research, said at its annual meeting in Whitehouse Station, N.J. Scolnick also said its joint venture with Schering-Plough Corp. (NYSE:SGP - news) to co-develop Schering's drug Ezetimibe was showing good results in the laboratory. The two drugmakers earlier this year agreed to develop the Schering medicine, which inhibits the intestine from absorbing cholesterol.
They are also developing a combination product that contains both Ezetimibe as well as a "statin" family cholesterol-lowering drug, such as Merck's Zocor. Scolnick said a trial conducted by Merck showed that combining Ezetimibe with any dose of Zocor reduced "bad" LDL cholesterol another 18 percent beyond Zocor's normal cholesterol-cutting ability. He predicted the combination product could become the most effective cholesterol-fighting product on the market if approved.
001211
RE001213
Copyright © 2000 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .